Overdose Risk
- PARIS (AP) — Over 32,000 boxes of Lisinopril, a generic medication used to treat hypertension and heart failure, have been recalled in France due to a printing...
- The ANSM stated that while the quality of the Lisinopril tablets, manufactured by Viatris, is not in question, a printing error on the blister packs could mislead...
- The recall affects four specific lots of Lisinopril 5 mg: 8172295, 8189879, 8172296, and 8192737, totaling 32,640 boxes, according to ANSM data.
Lisinopril Hypertension drug Recalled in France Over Printing Error
Table of Contents
- Lisinopril Hypertension drug Recalled in France Over Printing Error
- Lisinopril recall in France: Your Questions Answered
- What is Lisinopril, and what is it used for?
- Why was Lisinopril recalled in France?
- Who manufactured the recalled Lisinopril?
- What specific lots of Lisinopril were recalled?
- How many boxes of lisinopril were recalled in total?
- What are the risks of taking too much Lisinopril?
- What should I do if I have Lisinopril from one of the recalled lots?
- Are there any option medications available?
- Will there be a shortage of Lisinopril due to the recall?
- When will new Lisinopril lots with corrected packaging be available?
- What is the role of the ANSM in this recall?
- Where can I find more information about the Lisinopril recall?
PARIS (AP) — Over 32,000 boxes of Lisinopril, a generic medication used to treat hypertension and heart failure, have been recalled in France due to a printing error on the packaging that could lead to accidental overdose, the French National Agency for Medicines Safety (ANSM) announced Tuesday.
Packaging defect Sparks Recall
The ANSM stated that while the quality of the Lisinopril tablets, manufactured by Viatris, is not in question, a printing error on the blister packs could mislead patients. The agency said in a press release that the layout on the aluminum foil “can be confusing because it suggests that it is necessary to take several tablets certain days.”
Affected Lots
The recall affects four specific lots of Lisinopril 5 mg: 8172295, 8189879, 8172296, and 8192737, totaling 32,640 boxes, according to ANSM data.
Risks of Overdose
The ANSM warns that an overdose of Lisinopril may result in fatigue, balance issues, and hypotension. “Alteration of kidney function may occur,” the agency added. Thay also reported one instance of overdose that resulted in a patient experiencing confusion.
Alternative Medications Available
The agency anticipates that new Lisinopril lots with corrected packaging will “soon [be] available.” The ANSM dose not foresee any supply issues resulting from this recall, as “alternatives are available.”
According to the Vidal Data Database in France, other manufacturers, including Biogaran, Teva, Zentiva, Sandoz, and Arrow, also produce Lisinopril.
–With reporting from AFP
Lisinopril recall in France: Your Questions Answered
What is Lisinopril, and what is it used for?
Lisinopril is a generic medication used to treat hypertension (high blood pressure) and heart failure. It belongs to a class of drugs called ACE inhibitors (angiotensin-converting enzyme inhibitors).
Why was Lisinopril recalled in France?
Lisinopril was recalled in France due to a printing error on the packaging. This error could mislead patients and potentially lead to accidental overdose. Specifically, the layout on the aluminum foil blister packs was confusing and could suggest that patients needed to take multiple tablets on certain days.
Who manufactured the recalled Lisinopril?
The lisinopril tablets affected by the recall were manufactured by Viatris.
What specific lots of Lisinopril were recalled?
Four specific lots of Lisinopril 5 mg were recalled:
* 8172295
* 8189879
* 8172296
* 8192737
How many boxes of lisinopril were recalled in total?
A total of 32,640 boxes of Lisinopril were recalled.
What are the risks of taking too much Lisinopril?
An overdose of Lisinopril can lead to:
* fatigue
* Balance issues
* Hypotension (low blood pressure)
* Alteration of kidney function
* Confusion (in certain specific cases)
What should I do if I have Lisinopril from one of the recalled lots?
Contact your doctor or pharmacist for advice. They can help you determine if your medication is from a recalled lot and provide guidance on what steps to take.
Are there any option medications available?
Yes, the French National Agency for Medicines Safety (ANSM) anticipates that alternatives are available. Other manufacturers, including Biogaran, Teva, Zentiva, Sandoz, and Arrow, produce Lisinopril.
Will there be a shortage of Lisinopril due to the recall?
The ANSM does not foresee any supply issues resulting from the recall, as “alternatives are available.”
When will new Lisinopril lots with corrected packaging be available?
The ANSM anticipates new Lisinopril lots with corrected packaging will be available “soon”.
What is the role of the ANSM in this recall?
The ANSM (French National Agency for Medicines Safety) announced the recall and is responsible for monitoring the safety of medications in France.They are overseeing the recall process and ensuring patient safety.
Where can I find more information about the Lisinopril recall?
You can find more information on the ANSM website or by contacting your healthcare provider.